JazzIRT
Medical Properties Trust (NYSE:MPW) is expected to have a tough liquidity position in the coming quarters, plus its refinancing needs in the next three years are quite worrisome.
As I've covered previously, I have been bearish on MPW over
Should You Be Worried About Medical Properties Trust's Liquidity Profile?
Summary
- Medical Properties Trust (MPW) is expected to face liquidity issues in the coming quarters and has worrisome refinancing needs in the next three years.
- Despite cutting its dividend in half, MPW's dividend is still unsustainable, and a liquidity crunch is expected if management doesn't take action.
- MPW has been financing its dividend through asset sales and borrowings, but its cash position will change dramatically in December when a bond matures.
Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio management. Associated with the existing author The Outsider.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.